Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Maricel Apuli currently holds 129,401 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maricel Apuli has been a net seller of BBIO stock. They have purchased $0 and sold $280.5K worth of shares.
Maricel Apuli's most recent insider trade was on May 16, 2026, when they sold 4,714 shares at $66.13 per share.
Maricel Apuli serves as Executive at BridgeBio Pharma, Inc. (BBIO). They have executed 6 insider transactions totaling $280.5K over their tenure at the company.
Maricel Apuli holds the position of Executive at BridgeBio Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Maricel Apuli has shown a selling trading pattern, with $0 in total purchases and $280.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Maricel Apuli was on Nov 16, 2025, when they sold $317.4K worth of BBIO shares. This transaction involved 4,781 shares at $66.39 per share.
Maricel Apuli currently owns 129,401 shares of BridgeBio Pharma, Inc. (BBIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Maricel Apuli's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Maricel Apuli has 6 Form 4 filings on record as an insider at BridgeBio Pharma, Inc..
Set alerts for Maricel Apuli and 40,000+ other insiders.